These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6256850)
21. The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse. Lavine RL; Voyles N; Perrino PV; Recant L Endocrinology; 1975 Sep; 97(3):615-20. PubMed ID: 170069 [TBL] [Abstract][Full Text] [Related]
22. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody. Arshadi D; Nikbin B; Shakiba Y; Kiani A; Jamshidi AR; Boroushaki MT Int Immunopharmacol; 2013 Nov; 17(3):763-7. PubMed ID: 24055018 [TBL] [Abstract][Full Text] [Related]
23. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans. Søvik O; Heiervang E; Aksnes L; Selvig S Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266 [TBL] [Abstract][Full Text] [Related]
24. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452 [TBL] [Abstract][Full Text] [Related]
25. Lack of a diurnal plasma adenosine 3',5'-monophosphate rhythm. Endres P; Roeren T J Clin Endocrinol Metab; 1979 May; 48(5):872-3. PubMed ID: 219012 [TBL] [Abstract][Full Text] [Related]
26. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Slot O; Brünner N; Locht H; Oxholm P; Stephens RW Ann Rheum Dis; 1999 Aug; 58(8):488-92. PubMed ID: 10419867 [TBL] [Abstract][Full Text] [Related]
27. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Vos K; Steenbakkers P; Miltenburg AM; Bos E; van Den Heuvel MW; van Hogezand RA; de Vries RR; Breedveld FC; Boots AM Ann Rheum Dis; 2000 Jul; 59(7):544-8. PubMed ID: 10873965 [TBL] [Abstract][Full Text] [Related]
28. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy. Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272 [TBL] [Abstract][Full Text] [Related]
29. Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation. Fraser DA; Thoen J; Rustan AC; Førre O; Kjeldsen-Kragh J Rheumatology (Oxford); 1999 Oct; 38(10):948-52. PubMed ID: 10534544 [TBL] [Abstract][Full Text] [Related]
30. Insulin secretion and cyclic adenosine 3', 5'-monophosphate levels in pancreatic islets of fed and fasted rats. Time course and dose kinetics during glucose stimulation. Bouman PR; Wolters GH; Konijnendijk W Diabetes; 1979 Feb; 28(2):132-40. PubMed ID: 217791 [TBL] [Abstract][Full Text] [Related]
31. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. Blonde L; Wehmann RE; Steiner AL J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610 [TBL] [Abstract][Full Text] [Related]
32. Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Hafström I; Ringertz B; Gyllenhammar H; Palmblad J; Harms-Ringdahl M Arthritis Rheum; 1988 May; 31(5):585-92. PubMed ID: 2837251 [TBL] [Abstract][Full Text] [Related]
34. Effect of synthetic 1-34 fragment of human parathyroid hormone on plasma adenosine 3',5'-monophosphate (cAMP) concentrations and the diagnostic criteria based on the plasma cAMP response in Ellsworth-Howard test. Sohn HE; Furukawa Y; Yumita S; Miura R; Unakami H; Yoshinaga K Endocrinol Jpn; 1984 Feb; 31(1):33-40. PubMed ID: 6329666 [TBL] [Abstract][Full Text] [Related]
36. Dynamics of cAMP/cGMP in patients under a stress state. Chen P; Chai Y Chin J Traumatol; 2002 Apr; 5(2):115-7. PubMed ID: 11904075 [TBL] [Abstract][Full Text] [Related]
37. Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions. Caniggia A; Gennari C; Lore F; Nuti R; Galli M Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):99-105. PubMed ID: 6257524 [TBL] [Abstract][Full Text] [Related]
38. [Cyclic adenosine monophosphate concentration in the blood plasma in coronary arteriosclerosis and its relationship to the nature of the metabolic disorders]. Bobkova VI; Sidakova NM; Iurkiv VA; Oparina EI; Sukasova TI Kardiologiia; 1980 Mar; 20(3):87-91. PubMed ID: 6246304 [TBL] [Abstract][Full Text] [Related]
39. Effect of glucagon infusion on blood glucose, plasma immunoreactive insulin, growth hormone and adenosine 3'5'-monophosphate in obese children. Molnár D; Kardos M; Soltész G Acta Paediatr Acad Sci Hung; 1981; 22(4):325-9. PubMed ID: 6282041 [TBL] [Abstract][Full Text] [Related]
40. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]